US SB1287 | 2021-2022 | 117th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on April 21 2021 - 25% progression
Action: 2021-04-21 - Read twice and referred to the Committee on Finance. (text: CR S2126-2127)
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) in relation to discarded amounts (i.e., amounts remaining after administration) of single-dose vial drugs that are covered under Medicare. Manufacturers that fail to comply are subject to civil penalties. The CMS must determine rebate amounts based on payment claims from providers. (Currently, providers may receive payment under Medicare for discarded amounts of single-dose vial drugs through the use of a specific claims modifier.)

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

REFUND Act of 2021 Recovering Excessive Funds for Unused and Needless Drugs Act of 2021

Sponsors


History

DateChamberAction
2021-04-21SenateRead twice and referred to the Committee on Finance. (text: CR S2126-2127)

Same As/Similar To

SB2164 (Related) 2021-06-22 - Read twice and referred to the Committee on Finance.

Subjects


US Congress State Sources


Bill Comments

feedback